Viewpoint: United Kingdom highlights biomanufacturing capabilities

Linda Magee;

Publication

Article

June 15, 2002

BioPharm International

BioPharm International-06-01-2002

Volume15

Issue 6

Viewpoint: United Kingdom highlights biomanufacturing capabilities

Author(s):

Linda Magee

by Linda Magee, Bionow The United Kingdom has the second largest biotechnology industry in the world, a leading position in Europe, an excellent science base, proven capability in the development of drug candidates, and a record of several firsts in technology development.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Negotiating and Structuring Strategic Alliances

Finding Funding in Biotechnology: Keeping the Companies Alive

Biotechnology Patent Holders Beware! A Supreme Court Ruling may Significantly Reduce the Value of Your Patent Portfolio

Guest Editorial: Enabling Collaboration in the Pharmaceutical Industry

Stem Cells and Xenotransplantation: Ethics, Patents, and Politics

Unlocking the Value of R&D: Managing the Risks

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Viewpoint: United Kingdom highlights biomanufacturing capabilities

Newsletter